Lupin

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE326A01037
  • NSEID: LUPIN
  • BSEID: 500257
INR
2,275.00
-85 (-3.6%)
BSENSE

Aug 10, 03:30 PM

BSE+NSE Vol: 39.59 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Part of MojoOne Strategy
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Zydus Lifesci.
Laurus Labs
Sun Pharma.Inds.
Lupin
Divi's Lab.
Torrent Pharma
Mankind Pharma
Biocon
Aurobindo Pharma
Cipla
Dr Reddy's Labs

Why is Lupin Ltd. ?

1
Company has a Debt to Equity ratio (avg) of 0.11 times
2
Healthy long term growth as Net Sales has grown by an annual rate of 13.51% and Operating profit at 29.96%
3
The company has declared Positive results for the last 5 consecutive quarters
  • PAT(Latest six months) At Rs 2,975.39 cr has Grown at 49.40%
  • ROCE(HY) Highest at 27.06%
  • NET SALES(Q) Highest at Rs 8,276.89 cr
4
With ROE of 25.7, it has a Very Attractive valuation with a 4.6 Price to Book Value
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 18.69%, its profits have risen by 61.1% ; the PEG ratio of the company is 0.3
5
High Institutional Holdings at 47.07%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to Lupin should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Lupin for you?

Low Risk, High Return

Absolute
Risk Adjusted
Volatility
Lupin
18.69%
0.92
20.36%
Sensex
-1.65%
-0.12
13.58%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
13.51%
EBIT Growth (5y)
29.96%
EBIT to Interest (avg)
6.60
Debt to EBITDA (avg)
2.94
Net Debt to Equity (avg)
-0.12
Sales to Capital Employed (avg)
1.03
Tax Ratio
25.73%
Dividend Payout Ratio
16.70%
Pledged Shares
0
Institutional Holding
47.07%
ROCE (avg)
13.37%
ROE (avg)
12.32%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
17
Industry P/E
37
Price to Book Value
4.63
EV to EBIT
12.66
EV to EBITDA
10.63
EV to Capital Employed
5.11
EV to Sales
3.38
PEG Ratio
0.29
Dividend Yield
0.79%
ROCE (Latest)
37.51%
ROE (Latest)
25.68%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Bullish
OBV
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

19What is working for the Company
PAT(Latest six months)

At Rs 2,975.39 cr has Grown at 49.40%

ROCE(HY)

Highest at 27.06%

NET SALES(Q)

Highest at Rs 8,276.89 cr

OPERATING PROFIT TO INTEREST(Q)

Highest at 22.34 times

CASH AND CASH EQUIVALENTS(HY)

Highest at Rs 5,652.90 cr

0What is not working for the Company
Icon
NO KEY NEGATIVE TRIGGERS
Loading Valuation Snapshot...

Here's what is working for Lupin

Profit After Tax (PAT) - Latest six months
At Rs 2,975.39 cr has Grown at 49.40%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very positive

PAT (Rs Cr)

Net Sales - Quarterly
Highest at Rs 8,276.89 cr and Grown
each quarter in the last five quarters
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Operating Profit to Interest - Quarterly
Highest at 22.34 times
in the last five quarters
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Cash and Cash Equivalents - Half Yearly
Highest at Rs 5,652.90 cr
in the last six half yearly periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents